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Triglyceridesa b s t r a c t
Background: Prosthechea karwinskii is an endemic Mexican orchid, it’s currently used as decorative ele-
ment and in the traditional medicine to treat diabetes and some problems related to inflammatory pro-
cesses.
Aim: To determine antioxidant activity index (AAI) and to validate by the first time and through an rat
model the hydroalcoholic extract obtained from Prosthechea karwinskii, a plant used in traditional med-
icine for treat conditions relate to the metabolic syndrome.
Methods: For in vivo assays 25 weaned male Wistar rats were divided into a control group (CG; n = 5) and
a Metabolic Syndrome group (MS; n = 20). The rats of the latter were induced to MS with 40% sucrose in
the drink water during 13 weeks. After MS induction this group was subdivided into 4 groups: MS group
(n = 5) received sucrose, and three groups receiving 200 mg/kg of body weight of each extract pseudobulb
(P, n = 5), leaf (L, n = 5), and flower (F, n = 5). All treatments were followed for 13 days. Blood was col-
lected at the end of the study to measure glucose, cholesterol and triglycerides. AAI were measured in
the extracts by the method of DPPH. The results were analyzed using MINITAB 16.1.0, and the statistical
significance was determined by ANOVA and a Tukey’s test (P < 0.05).
Results: Leaves (L) extract had highest values in AAI, followed by flowers (F) and pseudobulb (P) extracts.
Leaves extract had highest reducing effect on glucose level, while flower extract had highest reducing
effect on the cholesterol and triglycerides levels.
Conclusions: The P. karwinskii extracts evaluated here reduces the glycemic and lipidemic parameters in
Wistar rats with MS induced. These effects may be attributed to the high antioxidant capacity of the
extracts.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Medicinal plants play an important role in the introduction of
new therapeutic agents as a source of biologically active sub-
stances with antihyperlipidemic and antihyperglycemic properties,
among other effects.1 Hyperglycemia results in an increased oxida-
tive stress due to reduced endogenous antioxidants in the body2
and imbalance in adipose tissue, influencing lipid regulation and
triggering cardiovascular disease. Metabolic syndrome (MS) is
the term used to designate a set of interrelated conditions thatinclude hyperglycemia, hyperlipidemia, obesity and hyperten-
sion.3–6 In traditional medicine, plants with biological activity
affecting metabolic disturbances related to the pathophysiology
of MS have been evaluated, including species from Orchidaceae
family. Asian orchids such as Nervilia plicata (Andrews) Schltr.,7
Dendrobium chrysotoxum Lindl.8 and Dendrobium denneanum
Kerr.,9 have shown to have hypoglycemic effects. In Mexico some
orchid species have also been evaluated for conditions related to
MS; Scaphyglottis fasciculate Hook. for its potential relaxing effect
on cardiac contractions,10 Laelia autumnalis (La Llave & Lex.) Lindl.
for its antihypertensive effect,11 Laelia anceps Lindl. for its antihy-
pertensive and vasorelaxant effects,12 and Prosthechea michuacana
(La Llave & Lex.) W.E. Higgins for its hypoglycemic activity.13
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used in the traditional medicine is Prosthechea karwinskii (Mart.) J.
M.H. Shaw. Different parts of this orchid are used as remedy to
treat hyperglycemia (pseudobulb and leaves), cough (pseudobulb
and flowers), burns (pseudobulb), and to prevent miscarriages
(flowers).14 The flowering of this species coincides with Easter cel-
ebrations and therefore this orchid is also used in religious decora-
tions at homes and churches.14–16 A previous phytochemical
study17 of our research group has identified the presence of pheno-
lic constituents in this orchid, like tyrosol, apigenin-7-glucoside,
caffeic acid, vainillin, p-cumaric acid and ferulic acid. These com-
pounds are known by their cardioprotective effects18,19 due to its
ability to inhibit cholesterol oxidation. Furthermore, phenolic com-
pounds can inhibit adipose tissue growth due to their antiangio-
genic activity and their ability to regulate adipocyte metabolism.20
The goal of this research was to determine the antioxidant
activity and to validate, by the first time, el traditional use of Pros-
thechea karwinskii in the treatment of some conditions relate to the
metabolic syndrome, for which some parts of the plant are
employed (pseudobulb, leaf, or flower). For this, the plant extracts
were obtained with ethanol-deionized water and then were evalu-
ated in a rat model.Table 1
Antioxidant capacity of Prosthechea karwinskii extracts.
Extract Yield w/w (%) IC50 AAI
Pseudobulb 18.8 ± 1.335 43.06 ± 7.311 0.925 ± 0.162
Leaf 16.8 ± 2.335 6.91 ± 0.187 5.7 ± 0.157
Flower 33.6 ± 2.93 30.85 ± 2.51 1.276 ± 0.971
IC50: 50% inhibitory concentration. AAI: antioxidant activity index = [DPPH]/IC50.2. Materials and methods
2.1. Plant material and extracts
Plant material was collected in 2012 and 2013 from specimens
that were used as Easter decorations in Villa de Zaachila, Oaxaca.
Additional material was collected in San Pedro and San Pablo
Teposcolula with the permission of the local authority. Taxonomic
determination of the plant was done and pressed specimens were
prepared and deposited in OAX Herbarium of the Instituto Politéc-
nico Nacional (Solano 4037). Since in traditional medicine is
known that each part of this orchid is used separately for particular
condition14, the plant material was separated into pseudobulbs,
leaves and flowers; each portion was dried, pulverized, and stored
at room temperature (R.T.) until use. Ten grams of each dried part
were placed in 400 ml of ethanol-deionized water solution (1:1, w/
v) for 7 days at R.T., frequently stirred, then filtered and concen-
trated by solvent evaporation at R.T. The yield of the extraction
for each plant part was: 18.8% for pseudobulbs, 16.8% for leaves,
and 33.6% for flower. The sticky extracts obtained were placed at
R.T. until it use.
2.2. Analysis of antioxidant activity index
Antioxidant capacity of the extracts was determined by the 2,2-
diphenyl-1-picrylhydrazyl radical (DPPH.) method; antioxidant
activity index (AAI) and IC50 values were determined according
to Sherer and Godoy.21
2.3. Sucrose-induced metabolic syndrome model
A total of 25 weaned male Wistar rats of 21 days age and 150–
200 g body weight (Table 2) were individually housed and main-
tained in a 12-h light/dark cycle at 25 C. This study was approved
by the Research Committee of the Universidad Cristobal Colón fol-
lowing the guidelines of Mexican legislation, NOM-062-ZOO-
199922 for the care and use of laboratory animals. Animals were
divided into two groups: the control group (CG; n = 5) was given
a standard diet (Lab Diet 2004 S, Harlan Teklad Inc.) andwater ad li-
bitum; the Metabolic Syndrome group (MS; n = 20) which was
given the same standard diet plus 40% sucrose in the drinking
water ad libitum for 13 weeks to induce MS.2.4. Experimental diet and co-treatment
After MS induction this group (n = 20) was subdivided into 4
groups: MS group (n = 5) received a high caloric sucrose diet, P
group (n = 5) received pseudobulb extract, L group (n = 5) received
leaf extract, and F group (n = 5) received flower extract; these
groups were compared with the control group (CG) as was men-
tioned above. P, L. and F groups received during 13 days by oral
via, through a standard esophageal cannula, 200 mg/kg of body
weight of the corresponding evaluated extract dissolved in water.
Animals from all groups received the previously mentioned stan-
dard diet, during the same period of 13 days; additionally, for the
MS group its diet included 40% sucrose in the drinking water ad li-
bitum. At the end of the treatment the final weight was registered
and a blood sample was taken from each rat with 18-h-fasted using
cardiac puncture under anesthetic condition, prior to the killing of
the animals. The blood was centrifuged and serum was kept at
20 C until use.2.5. Adipose tissue and Biochemical parameters
At the end of the treatment, rats were killed with anesthesia
(0.1 ml intraperitoneal of 1% sodium barbiturate) to obtain the
abdominal adipose tissue, epididymal and pericardial fat, and to
determine the serum levels of glucose, cholesterol and triglyceride.
These parameters were determined by enzymatic-colorimetric
methods according to the manufacturer’s instruction using a
biochromatic analyzer model Vitalab Selectra E.2.6. Data analysis
Data obtained from the serum parameters, weight gain, organs
and adipose tissue are presented as the mean ± SD. Data was eval-
uated using Minitab 16.1.0 software. Statistical significance was
determined with an analysis of variance, a Tukey’s multiple range
test was performed to test for significant differences between the
different treatment groups. For all analyses the level of significance
was P < 0.05.3. Results
3.1. Total flavonoids and antioxidant activity of Prosthechea
karwinskii extracts
Table 1 presents the concentration required to inhibit 50% of
free radicals (IC50), antioxidant activity index (AAI), and total flavo-
noid content of the extracts administered for biological evaluation.
The highest antioxidant capacity was showed by the extract of
leaves (AAI = 5.7), followed by that from flowers (AAI = 1.276), and
pseudobulbs (AAI = 0.925).3.2. Caloric intake induced MS model
The daily caloric intake of the MS group compared with that of
the control group (CG) during the 13 weeks MS induction period is
Fig. 1. Caloric intake during Metabolic Syndrome development. CG: control group,
MS: sucrose diet, kcal: kilocalories. The values represent the mean ± DS ⁄P < 0.05.
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the CG due to sucrose consumption.
Table 2 shows the caloric intake of CG, MS, P, L and F groups
during 13 days of treatment consisting in the administration of
the extracts and sucrose water. The initial weight for each evalu-
ated group was nonuniform because evaluation of extracts began
after induction of the animal model metabolic syndrome with
40% sucrose in drinking water; also, it must be considered the vari-
ation presented in the caloric intake of the animals during the
development of MS, as is shown in Fig. 1.
Body weight of the CG increased by 1.1% while the body weight
of the MS group increased by 5.6%. After the treatment, the P group
lost the most weight, 7.8% of the total weight. Body weight of the L
group decreased by 5.2% whereas that of the F group decreased by
5%, these results were respect to MS group.3.3. Effect of Prosthechea karwinskii extracts in adipose tissue and
serum parameters
Table 3 shows the effect of P. karwinskii extracts on abdominal,
epididymal and pericardial adipose tissue weight over the 13 days
experimental treatment.
In comparison with the MS group, the other groups experienced
significant decreases in total adipose tissue: 49% in the P group,
36% in the L group, and 33% in the F group. According to the serum
parameters of the CG and the MS group, glucose, cholesterol and
triglycerides levels decreased in three groups: P, L and F (Table 4).
The leaf extract (L) had greatest effect in decrease the fasting
glucose levels (64.12 mg/dl) in comparison with the MS group
(135.26 mg/dl). The other extracts (F and P) also decreased glucose
levels to 73.72 and 92.20 mg/dl, respectively. The flower extract (F)
had the greatest effect on cholesterol levels (53.89 mg/dl) com-
pared to the MS group (87.52 mg/dl); cholesterol levels in the CG
were 69.43 mg/dl. P and L extracts also decreased this parameterTable 2
Caloric intake and body weight of rats under the effect of P. karwinskii extracts after 13 d
Parameter CG MS
kcal/day (B) 65.10 ± 19.53 125.68 ± 22.62a
Initial weight (g) 372.0 ± 70.14 440.0 ± 83.19
kcal/day (E) 79.05 ± 6.48 139.42 ± 6.77a
Final weight (g) 376.0 ± 77.73 464.50 ± 44.04
CG: control group, MS: sucrose diet, P: sucrose diet and pseudobulb extract, L: sucrose di
E: End of the treatment. The values represent the mean ± SD, superscript values show s
a P < 0.05.but in a lesser extent: 75.55 mg/dl and 76.04 mg/dl, respectively.
The extracts also had a reductive effect on triglyceride levels com-
pared to the CG and MS groups, 214.28 and 259.28 mg/dl, respec-
tively. The F group had the lowest triglycerides level (74.58 mg/dl),
followed by L (108.78 mg/dl) and P (127.75 mg/dl) groups
(Table 4).4. Discussion
This work reveals by the first time that the pseudobulb, leaf and
flower hydroalcoholic extracts from P. karwinskii ameliorated key
parameters of the MS in a rat model and their relation with antiox-
idant capacity of the extracts. At the end of the treatment, the
group given pseudobulb extract lost the greatest percentage of
body weight, followed by the groups that received leaf and flower
extracts. The results indicate that the evaluated extracts, adminis-
tered in a dose of 200 mg/kg/day, significantly decreased adipose
tissue mass and serum parameters levels that are associated with
MS. The extracts evaluated here, not only reduced the adipose tis-
sue mass but glucose levels as well; in contrast the results reported
for aqueous extract from Ilex paraguariensis A. St.-Hil.23 reduced
abdominal and epididymal adipose tissue too, but raised glucose
levels during 30 days of treatment. As the adiposity index data
reveals, Prosthechea karwinskii extracts also had a greater effect
on reducing adipose tissue than the previously reported for Salacia
reticulate Wight24 and Citrus grandis (L.) Osbeck.25
The extracts also had a lowering effect on cholesterol and
triglycerides levels; in this case, the flower extract had a greater
effect than the reported for Camellia sinensis (L.) Kuntze.26 Evalua-
tion of Citrus grandis hydroalcoholic extract25 indicates that after
two weeks of treatment with a higher administered dose, choles-
terol levels remained higher than our results. The dosage of leaf
extract evaluated here had a greater glucose lowering effect than
that reported for the polysaccharide obtained from Dendrobium
chrysotoxum pseudobulbs8 using dosage of 200 mg/kg/day and
500 mg/kg/day. The leaf extract evaluated here also has a better
dampening effect than the reported for Dendrobium denneanum
polysaccharide9 using a dose of 300 mg/kg/day.
The antihyperglycemic effect of leaf extract in this work could
be attributed to its greater antioxidant capacity compared with
that for pseudobulb and flower extracts. Since hyperglycemia is
associated with diminished endogenous antioxidants and
increased oxidative stress, antioxidants have been shown to reduce
the risk of hyperglycemia improving glucose disposal in the
body.5,27,28 According to the methodology described by Sherer
and Godoy,21 these results show that P. karwinskii extracts have a
higher AAI (Table 1) than other species reported in the following
studies: ethanol-water leaves extract from Dendrobium speciosum
Sm.29 with IAA of 3.46 ⁄ 105, the hydromethanolic and chloroform
pseudobulb extracts from Prosthechea michuacana with an AAI of
0.0901 and 0.1268, respectively,13 the hydrometanolic rhizomes
extract from Curculigo orchioides Gaertn.30 with an AAI = 0.3720,
the hydrometanolic leaf extract of Juglans regia L.31 with an
AAI = 1.98 ⁄ 109, and Jasminum humile L.32 with an AAI = 0.5598.ays of experimental treatment.
P L F
87.43 ± 2.38 91.27 ± 10.38 81.30 ± 9.26
321.67 ± 96.3 385.0 ± 69.28 431.67 ± 23.63
128.35 ± 6.47a 147.93 ± 31.13a 147.78 ± 13.96a
296.67 ± 88.8 365.0 ± 73.65 410.0 ± 20.00
et and leaf extract, F: sucrose diet and flower extract, B: Beginning of the treatment,
tatistically significant difference as revealed by the Tukey’s test.
Table 3
Abdominal, epididymal and pericardial adipose tissue weight and adiposity index after co-treatment with P. karwinskii extracts.
Parameter (g) GC MS P L F
AT abdominal 12.20 ± 1.92 16.25 ± 5.91 9.33 ± 3.78a 11.66 ± 2.30 11.0 ± 1.73a
AT epididymal 10.0 ± 2.55 15.83 ± 6.67 6.66 ± 2.08a 8.33 ± 2.88a 10.33 ± 0.57a
AT pericardial 0.62 ± 0.40 0.48 ± 0.18 0.70 ± 0.26 0.56 ± 0.30 0.40 ± 0.10
Total fat 22.82 ± 4.87 32.56 ± 12.76 16.69 ± 6.12a 20.55 ± 5.48a 21.73 ± 2.4a
AT: adipose tissue, GC: control group, MS: sucrose diet, P: sucrose diet and pseudobulb extract, L: sucrose diet and leaf extract, F: sucrose diet and flower extract. The values
represent the mean ± SD, superscript values show statistically significant difference as revealed by the Tukey’s test.
a P < 0.05.
Table 4
Variation of serum parameters in Wistar rats after 13 days of treatment with P. karwinskii extracts.
Parameter (mg/dl) CG MS P L F
Glucose 96.80 ± 10.64a 135.26 ± 30.70 92.20 ± 7.95a 64.12 ± 11.39a 73.72 ± 25.76a
Cholesterol 69.43 ± 10.39a 87.52 ± 7.44 75.55 ± 0.32a 76.04 ± 9.59a 53.89 ± 10.54a
Triglycerides 214.28 ± 18.07a 259.28 ± 23.89 127.75 ± 46.56a 108.78 ± 11.30a 74.58 ± 22.35a
CG: control group, MS: sucrose diet, P: sucrose diet and pseudobulb extract, L: sucrose diet and leaf extract, F: sucrose diet and flower extract. The values represent the
mean ± SD, superscript values show statistically significant difference as revealed by the Tukey’s test.
a P < 0.05.
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of compounds previously identified in P. karwinskii by Mijangos-
Ricardez and López-Luna.17
Polyphenolic compounds also have been considered as a poten-
tial alternative for the treatment of MS given their effect in the
absorption and metabolism of simple carbohydrates,18,33 mainly
reflected in the hypoglycemic and hypolipidemic effect of the
extracts evaluated in this work. Recent studies have established
that phenolic and flavonoid compounds are both capable of
inhibiting lipid accumulation and apoptosis induction,34 although
they regulate the adipocyte physiology in a different way. An
hypercaloric diet and genetic predisposition are the immediate
causes of developing MS risk factors, such as obesity, insulin resis-
tance, hyperlipidemia and hypertension, as well as of other meta-
bolic diseases such as type II diabetes and cardiovascular disease.35
In this work the hypercaloric diet (40% sucrose solution) adminis-
tered at the beginning of the experiments was the principal factor
who caused MS in the rats, thereby this work demonstrates that
the extracts herein evaluated decreased the adiposity index and
thus its relationship with associated metabolic disorders (hyper-
glycemia, hypercholesterolemia and hypertriglyceridemia).
Prosthechea karwisnkii extracts, by reducing adipose tissue, may
also decrease characteristics MS serum parameters. This is because
adipose tissue regulates the activation of macrophages, which
favor the secretion of adipokines that regulates insulin resistance
and the accumulation of triglycerides and cholesterol caused by
increase of adiponectin and leptin secretions, in order to maintain
equilibrium with the excess nutrients consumed by the organ-
ism.34,35 For this reason, is require carry out studies that allow to
evaluate the effect of the extracts on adipose tissue and dyslipi-
demia in a MS rat model, this research are actually in progress.
In conclusion, the hydroalcoholic extracts studied hereof represent
an alternative for the treatment of MS in the traditional medicine.
Their reductive effect was showed even with the continued admin-
istration of a hyper-caloric diet to the groups treated with the
extracts.Conflict of interest statement
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